430 related articles for article (PubMed ID: 25579574)
21. Computational Drug Repurposing: Current Trends.
Karaman B; Sippl W
Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
[TBL] [Abstract][Full Text] [Related]
22. An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs.
Hosomi K; Fujimoto M; Ushio K; Mao L; Kato J; Takada M
PLoS One; 2018; 13(10):e0204648. PubMed ID: 30300381
[TBL] [Abstract][Full Text] [Related]
23. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
Sahu NU; Kharkar PS
Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
[TBL] [Abstract][Full Text] [Related]
24. Computational drug repositioning for cancer therapeutics.
Jiao M; Liu G; Xue Y; Ding C
Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
[TBL] [Abstract][Full Text] [Related]
25. New Therapeutic Uses for Existing Drugs.
Austin BA; Gadhia AD
Adv Exp Med Biol; 2017; 1031():233-247. PubMed ID: 29214576
[TBL] [Abstract][Full Text] [Related]
26. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
Liu H; Song Y; Guan J; Luo L; Zhuang Z
BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
[TBL] [Abstract][Full Text] [Related]
27. Web-based drug repurposing tools: a survey.
Sam E; Athri P
Brief Bioinform; 2019 Jan; 20(1):299-316. PubMed ID: 29028878
[TBL] [Abstract][Full Text] [Related]
28. Drug repositioning: re-investigating existing drugs for new therapeutic indications.
Padhy BM; Gupta YK
J Postgrad Med; 2011; 57(2):153-60. PubMed ID: 21654146
[TBL] [Abstract][Full Text] [Related]
29. Drug repurposing by integrated literature mining and drug-gene-disease triangulation.
Sun P; Guo J; Winnenburg R; Baumbach J
Drug Discov Today; 2017 Apr; 22(4):615-619. PubMed ID: 27780789
[TBL] [Abstract][Full Text] [Related]
30. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.
Jin G; Wong ST
Drug Discov Today; 2014 May; 19(5):637-44. PubMed ID: 24239728
[TBL] [Abstract][Full Text] [Related]
31. Time-resolved evaluation of compound repositioning predictions on a text-mined knowledge network.
Mayers M; Li TS; Queralt-Rosinach N; Su AI
BMC Bioinformatics; 2019 Dec; 20(1):653. PubMed ID: 31829175
[TBL] [Abstract][Full Text] [Related]
32. DrPOCS: Drug Repositioning Based on Projection Onto Convex Sets.
Wang YY; Cui C; Qi L; Yan H; Zhao XM
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(1):154-162. PubMed ID: 29993698
[TBL] [Abstract][Full Text] [Related]
33. In silico repositioning of approved drugs for rare and neglected diseases.
Ekins S; Williams AJ; Krasowski MD; Freundlich JS
Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
[TBL] [Abstract][Full Text] [Related]
34. Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering-A Cross-Sectional Analysis.
Stockklausner C; Lampert A; Hoffmann GF; Ries M
Oncologist; 2016 Apr; 21(4):487-93. PubMed ID: 27022038
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in drug repositioning for the discovery of new anticancer drugs.
Shim JS; Liu JO
Int J Biol Sci; 2014; 10(7):654-63. PubMed ID: 25013375
[TBL] [Abstract][Full Text] [Related]
36. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
Zhao K; So HC
Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
[TBL] [Abstract][Full Text] [Related]
37. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
[TBL] [Abstract][Full Text] [Related]
38. Drug repurposing in rare diseases: Myths and reality.
Fetro C; Scherman D
Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
[TBL] [Abstract][Full Text] [Related]
39. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
